Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
110
Share acquisition rights (decrease)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Partial changes to and finalization of the issuance terms of stock options (share acquisition rights)
Who receives how much
Portion Granted to Directors and Other Officers The Company's common shares 1,728,000 shares / Portion Granted to Employees The Company's common shares 9,631,700 shares / Total The Company's common shares 11,359,700 shares
The Company's directors and executive officers, and the directors, audit & supervisory board members and executive officers of its subsidiariesThe Company's common shares 1,728,000 shares
1,487 Company employees, 3,275 employees of the Company's subsidiaries (total: 4,762 people)The Company's common shares 9,631,700 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
Terms of the stock acquisition rights
Exercise price
¥122,800 per share acquisition right (¥1,228 per share). Amendment provisions: Not disclosed
Exercise period
From 16 September 2029 to 15 September 2031
Number of Stock Acquisition Rights
Total issued: 113,597 share acquisition rights. Unexercised balance: Not disclosed
Categories and Number of Persons Covered
Category The Company's directors and executive officers, and the directors, audit & supervisory board members and executive officers of its subsidiaries / Number of Employees 79 / Number of allocated shares The Company's common shares 1,728,000 shares, Category Employees of the Company / Number of Employees 1,487 / Number of allocated shares Not disclosed, Category Employees of the Company’s subsidiaries / Number of Employees 3,275 / Number of allocated shares Not disclosed
Basis for determining the amount to be paid
The closing price in regular trading of the Company's common stock on the Tokyo Stock Exchange on the date of allotment of the stock acquisition rights, or, if no trade is concluded, the closing price on the most recent preceding trading day
| Item | Details |
|---|---|
| Type of issuance or disposal | Partial changes to and finalization of the issuance terms of stock options (share acquisition rights) |
| Number of shares to be issued or disposed of | Portion Granted to Directors and Other Officers The Company's common shares 1,728,000 shares / Portion Granted to Employees The Company's common shares 9,631,700 shares / Total The Company's common shares 11,359,700 shares |
| Intended allottee | Category The Company's directors and executive officers, and the directors, audit & supervisory board members and executive officers of its subsidiaries / Number of Shares The Company's common shares 1,728,000 shares, Category 1,487 Company employees, 3,275 employees of the Company's subsidiaries (total: 4,762 people) / Number of Shares The Company's common shares 9,631,700 shares |
| Basis for determining the amount to be paid | The closing price in regular trading of the Company's common stock on the Tokyo Stock Exchange on the date of allotment of the stock acquisition rights, or, if no trade is concluded, the closing price on the most recent preceding trading day |
| Exercise price | ¥122,800 per share acquisition right (¥1,228 per share). Amendment provisions: Not disclosed |
| Exercise period | From 16 September 2029 to 15 September 2031 |
| Number of Stock Acquisition Rights | Total issued: 113,597 share acquisition rights. Unexercised balance: Not disclosed |
| Categories and Number of Persons Covered | Category The Company's directors and executive officers, and the directors, audit & supervisory board members and executive officers of its subsidiaries / Number of Employees 79 / Number of allocated shares The Company's common shares 1,728,000 shares, Category Employees of the Company / Number of Employees 1,487 / Number of allocated shares Not disclosed, Category Employees of the Company’s subsidiaries / Number of Employees 3,275 / Number of allocated shares Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because changes in the persons eligible for allotment due to retirement or other reasons through 30 September 2026 were reflected. The exercise price was determined based on the closing price of the Company's common shares on the Tokyo Stock Exchange on the date the share acquisition rights were allotted.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.